Role of CD9 in proliferation and proangiogenic action of human adipose-derived mesenchymal stem cells

Pflugers Archiv European Journal of Physiology

Volumn 455, Issue 2, 2007, Pages 283-296

  Kim, Yeon Jeong ^a   Yu, Ji Min ^a   Joo, Hye Joon ^a   Kim, Hoe Kyu ^a   Cho, Hyun Hwa ^a   Bae, Yong Chan ^a   Jung, Jin Sup ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Adhesion; Adipose tissue; Angiogenesis; CD9; Mesenchymal stem cells; Proliferation

Indexed keywords

ANTIBODY; CD9 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; MICRORNA;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL KINETICS; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENGRAFTMENT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LENTIVIRINAE; LIMB ISCHEMIA; MESENCHYMAL STEM CELL; MOLECULAR CLONING; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD; BIOLOGICAL MARKERS; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HINDLIMB; HUMANS; ISCHEMIA; MEMBRANE GLYCOPROTEINS; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION;

EID: 35148855060     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-007-0285-4     Document Type: Article

References (70)

1. Levy S, Shoham T (2005) Protein-protein interactions in the tetraspanin web. Physiology (Bethesda) 20:218-224
2. Hemler ME (2005) Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6(10):801-811 (Review, Oct)
3. Maecker HT, Todd SC, Levy S (1997) The tetraspanin superfamily: molecular facilitators. FASEB J 11:428-442
4. Boucheix C, Rubinstein E (2001) Tetraspanins. Cell Mol Life Sci 58(9):1189-1205 (Aug)
5. Kovalenko OV, Metcalf DG, DeGrado WF, Hemler ME (2005) Structural organization and interactions of transmembrane domains in tetraspanin proteins. BMC Struct Biol 5:11 (Jun 28)
6. Charrin S, Le Naour F, Oualid M, Billard M, Faure G, Hanash SM, Boucheix C, Rubinstein E (2001) The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J Biol Chem 276:14329-14337
7. Boucheix C, Perrot JY, Mirshahi M (1985) A new set of monoclonal antibodies against acute lymphoblastic leukemia. Leuk Res 9:597-604
8. Sincock PM, Mayrhofer G, Ashman LK (1997) Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and alpha5beta1 integrin. J Histochem Cytochem 45(4):515-525
9. Miyake M, Koyama M, Seno M (1991) Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med 174:1347-1354
10. Takeda Y, Tachibana I, Miyado K (2003) Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes. J Cell Biol 16:945-956
11. Miyake M, Nakano K, Ieki Y (1995) Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res 55:4127-4131
12. Miyake M, Inufusa H, Adachi M (2000) Suppression of pulmonary metastasis using adenovirally motility related protein-1 (MRP-1/CD9) gene delivery. Oncogene 19:5221-5226
13. Hadjiargyrou M, Patterson PH (1995) An anti-CD9 monoclonal antibody promotes adhesion and induces proliferation of Schwann cells in vitro. J Neurosci 15:574-583
14. Tachibana I, Bodorova J, Berditchevski F (1997) NAG-2, a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins. J Biol Chem 272:29181-29189
15. Chen MS, Tung KS, Coonrod SA (1999) Role of the integrin-associated protein CD9 in binding between sperm ADAM 2 and the egg integrin alpha6beta1: implications for murine fertilization. Proc Natl Acad Sci USA 96:11830-11835
16. Le Naour F, Rubinstein E, Jasmin C, Prenant M, Boucheix C (2000) Severely reduced female fertility in CD9-deficient mice. Science 287(5451):319-321
17. Miyado K, Yamada G, Yamada S, Hasuwa H, Nakamura Y, Ryu F, Suzuki K, Kosai K, Inoue K, Ogura A, Okabe M, Mekada E (2000) Requirement of CD9 on the egg plasma membrane for fertilization. Science 287(5451):321-324
18. Kaji K, Oda S, Shikano T, Ohnuki T, Uematsu Y, Sakagami J, Tada N, Miyazaki S, Kudo A (2000) The gamete fusion process is defective in eggs of Cd9-deficient mice. Nat Genet 24(3):279-282
19. Inui S, Higashiyama S, Hashimoto K (1997) Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth. J Cell Physiol 171:291-298
20. Shi W, Fan H, Shum L (2000) The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation. J Cell Biol 148:591-602
21. Si Z, Hersey P (1993) Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma. Int J Cancer 54:37-43
22. Mori M, Mimori K, Shiraishi T (1998) Motility related protein 1 (MRP1/CD9) expression in colon cancer. Clin Cancer Res 4:1507-1510
23. Mhawech P, Herrmann F, Coassin M (2003) Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression. Cancer 98:1649-1657
24. Higashiyama M, Taki T, Ieki Y (1995) Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res 55:6040-6044
25. Sho M, Adachi M, Taki T (1998) Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer 79:509-516
26. Erovic BM, Pammer J, Hollemann D (2003) Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma. Head Neck 25:848-857
27. Mhawech P, Dulguerov P, Tschanz E (2004) Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck. Br J Cancer 90:471-475
28. Miyake M, Nakano K, Itoi SI (1996) Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res 56:1244-1249
29. Murayama Y, Miyagawa J, Oritani K (2004) CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells. Cell Sci 117:3379-3388
30. Ikeyama S, Koyama M, Yamaoko M (1993) Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 177:1231-1237
31. Huang CL, Liu D, Masuya D (2004) MMRP-1/CD9 gene transduction downregulates Wnt signal pathways. Oncogene 23:7475-7483
32. Ko EM, Lee IY, Cheon IS (2006) Monoclonal antibody to CD9 inhibits platelet-induced human endothelial cell proliferation. Mol Cells 22:70-77
33. Jennings LK, Crossno JT Jr, White MM (2000) CD9 structure and function. In: Berndt MC (ed) Platelets, thrombosis and the vessel wall. Harwood Academic Publishers, Amsterdam, Holland, pp 173-187
34. Shaw ARE, Domanska A, Mak A (1995) Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin dependent motility on FN and LN substrates and enhanced tyrosine phosphorylation. J Biol Chem 270:24092-24099
35. Cook GA, Longhurst CM, Grgurevich S, Cholera S, Crossno JT Jr, Jennings LK (2002) Identification of CD9 extracellular domains important in regulation of CHO cell adhesion to fibronectin and fibronectin pericellular matrix assembly. Blood 100(13):4502-4511
36. Friedenstein AJ, Chailakhyan RK, Gerasimov UV (1987) Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20:263-272
37. Friedenstein AJ, Gorskaja JF, Kulagina NN (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267-274
38. Friedenstein AJ, Latzinik NW, Grosheva AG (1982) Marrow microenvironment transfer by heterotopic transplantation of freshly isolated and cultured cells in porous sponges. Exp Hematol 10:217-227
39. Pittenger MF, Mackay AM, Beck SC (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
40. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74
41. Liechty KW, MacKenzie TC, Shaaban AF (2000) Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature Medicine 6:1282-1286
42. Zuk PA, Zhu M, Mizuno H (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211-228
43. Schaffler A, Buchler C (2007) Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 25(4):818-827
44. Safford KM, Hicok KC, Safford SD (2002) Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 294:371-379
45. Cho HH, Bae YC, Jung JS (2006) Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 24:2744-2752
46. Lee DH, Kang SK, Lee RH (2004) Effects of peripheral benzodiazepine receptor ligands on proliferation and differentiation of human mesenchymal stem cells. J Cell Physiol 198:91-99
47. Kang SK, Lee DH, Bae YC (2003) Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 183:355-366
48. Gronthos S, Franklin DM, Leddy HA (2001) Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189:54-63
49. Oritani K, Aoyama K, Tomiyama Y, Kincade PW, Matsuzawa Y (2000) Stromal cell CD9 and the differentiation of hematopoietic stem/progenitor cells. Leuk Lymphoma 38(1-2):147-152 (Review)
50. Moon MH, Kim SY, Kim YJ (2006) Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cell Physiol Biochem 17:279-290
51. Cook GA, Wilkinson WA, Crossno JT Jr (1999) The tetraspanin CD9 influences the adhesion, spreading, and pericellular FN matrix assembly of Chinese hamster ovary cells on human plasma FN. Exp Cell Res 251:356-371
52. Nakai K, Tanaka T, Murai T (2005) Invasive human pancreatic carcinoma cells adhere to endothelial tri-cellular corners and increase endothelial permeability. Cancer Sci 96:766-773
53. Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering FNAsin mammalian cells. Science 296:550-553
54. Manning AM, Bell FP, Rosenbloom CL (1995) NF-kappa B is activated during acute inflammation in vivo in association with elevated endothelial cell adhesion molecule gene expression and leukocyte recruitment. J Inflam 45:283-296
55. Planat-Benard V, Menard C, Andre M, Puceat M, Perez A, Garcia-Verdugo JM, Penicaud L, Casteilla L (2004) Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 94(2):223-229
56. Seehafer JG, Shaw AR (1991) Evidence that the signal-initiating membrane protein CD9 is associated with small GTP-binding proteins. Biochem Biophys Res Commun 179:401-406
57. Kroll MH, Mendelsohn ME, Miller JL (1992) Monoclonal antibody AG-1 initiates platelet activation by a pathway dependent on glycoprotein IIb-IIIa and extracellular calcium. Biochim Biophys Acta 1137:248-256
58. Zilber MT, Setterblad N, Vasselon T (2005) Institut National de la Sante et de la Recherche Medicale (INSERM) U662, and Service Commun MHC class II/CD38/CD9: a lipid-raft-dependent signaling complex in human monocytes. Blood 106:3074-3081
59. Chung J, Mercurio AM (2004) Contributions of the alpha6 integrins to breast carcinoma survival and progression. Mol Cells 17:203-209
60. Klein-Soyer C, Azorsa DO, Cazenave JP (2000) CD9 participates in endothelial cell migration during in vitro wound repair. Arterioscler Thromb Vasc Biol 20:360-369
61. Slupsky JR, Cawley JC, Kaplan C (1997) Analysis of CD9, CD32 and p67 signalling: use of degranulated platelets indicates direct involvement of CD9 and p67 in integrin activation. Br J Haematol 96:275-286
62. Le Naour F, Andre M, Boucheix C, Rubinstein E (2006) Membrane microdomains and proteomics: lessons from tetraspanin microdomains and comparison with lipid rafts. Proteomics 6(24):6447-6454 (Review)
63. Le Naour F, Charrin S, Labas V, Le Caer JP, Boucheix C, Rubinstein E (2004) Tetraspanins connect several types of Ig proteins: IgM is a novel component of the tetraspanin web on B-lymphoid cells. Cancer Immunol Immunother 53(3):148-152 (Review)
64. Sugiura T, Berditchevski F (1999) Function of 31-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J Cell Biol 146:1375-1389
65. Hemler ME (1998) Integrin associated proteins. Curr Opin Cell Biol 10:578-585
66. Little KD, Hemler ME, Stipp CS (2004) Dynamic regulation of a GPCR-tetraspanin-G protein complex on intact cells: central role of CD81 in facilitating GPR56-Galpha q/11 association. Mol Biol Cell 15(5):2375-2387
67. Rahman A, Anwar KN, True AL, Malik AB (1999) Thrombin-induced p65 homodimer binding to downstream NF-κB site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. J Immunol 162:5466-5476
68. Robker RL, Collins RG, Beaudet AL, Mersmann HJ, Smith CW (2004) Leukocyte migration in adipose tissue of mice null for ICAM-1 and Mac-1 adhesion receptors. Obes Res 12(6):936-940 (Jun)
69. Duda DG, Fukumura D, Jain RK (2004) Role of eNOS in neovascularization: NO for endothelial progenitor cells. Trends Mol Med 10:143-145
70. Ying L, Hofseth LJ (2007) An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res 67(4):1407-1410 (Review)